DMD and Becker muscular dystrophy: We use CRISPR/Cas9 technology to generate bmx (Becker muscular dystrophy, X‐linked) mice, which express an in‐frame ~40 000 bp deletion of exons 45–47 in the murine Dmd gene, reproducing the most common BMD patient mutation.